Abnormal-finding sensitivity
93.2 percent
- EndpointBench abnormal-finding classification
- Population8,745 fetal ultrasound images from 1,115 examinations at 75 sites
- Tested versionSonio Suspect release reviewed in K243614
Authorized purpose: Concurrent or post-exam fetal ultrasound aid that identifies and characterizes eight abnormal findings for interpreting-physician review; not the sole basis for management.
Overview status: Source-reviewed overview
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
Clinical takeaway. Clinical role: Concurrent or post-exam fetal ultrasound aid that identifies and characterizes eight abnormal findings for interpreting-physician review; not the sole basis for management.
Evidence takeaway. Evidence from the reviewed source record: FDA bench testing used 8,745 images from 1,115 examinations at 75 sites and reported sensitivity 93.2% and specificity 90.8%; a separate 13-reader MRMC study used 750 images from 287 examinations at 47 sites and reported AUC 0.689 unassisted versus 0.909 assisted.
Evidence context not reviewed for this FDA record.
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Evidence
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Model sensitivity reported by ACR AI Central. Review endpoint, threshold, study population, and tested version before comparison.
Model specificity reported by ACR AI Central. Review endpoint, threshold, study population, and tested version before comparison.
93.2 percent
90.8 percent
0.689 AUC
0.909 AUC
K243614 FDA 510(k) summary bench study
The FDA summary reports an independent dataset for the bench analysis and 64 U.S. sites among the 75 sites.
K243614 FDA 510(k) summary MRMC study
Readers included maternal-fetal medicine, obstetrics and gynecology, and radiology clinicians; the FDA summary reports AUC improvement with assistance.
Safety and lifecycle
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.
Price not public here; enter your quote
Not publicly available: Reviewed sources do not publish an exact-product procurement price with a stated offer scope.
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Source context, not route validation: Fetal ultrasound images and examination views from supported GE, Philips, Samsung and Canon systems, uploaded or connected through the workflow.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Field checked 2026-09-06 · FDA 510(k) decision record and summary reviewed for Sonio Suspect, K243614
Source context, not route validation: The current Sonio family platform page describes DICOM worklist and PACS/VNA integration, HL7/FHIR and EHR connectivity, and support across ultrasound manufacturers. The page's current clinical-AI footnote refers to Sonio Detect, so these family capabilities are not asserted as exact K243614 interfaces.
Scope: Product family.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Field checked 2026-09-07 · Sonio clinical workflow and interoperability platform
Source context, not route validation: The exact materials describe a SaaS web application accessible from an internet-connected tablet or computer during or after fetal ultrasound, with uploaded images or an ultrasound-system connection.
Scope: Exact FDA submission.
Confirm processing location, queue ownership, exclusions and exact AI build.
Field checked 2026-09-06 · FDA 510(k) decision record and summary reviewed for Sonio Suspect, K243614
Source context, not route validation: Per-view statuses of Suspected, Not Suspected or Can't be analyzed for supported abnormal findings, with user ability to manually override the output.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Field checked 2026-09-06 · FDA 510(k) decision record and summary reviewed for Sonio Suspect, K243614
Unresolved route: Per-view statuses of Suspected, Not Suspected or Can't be analyzed for supported abnormal findings, with user ability to manually override the output.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Field checked 2026-09-06 · FDA 510(k) decision record and summary reviewed for Sonio Suspect, K243614
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
No tests below have been performed or accepted.
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
Vendor statement, not an attestation; exact-release scope is not established.
The exact FDA materials describe a web application accessed from an internet-connected tablet or computer during or after the fetal ultrasound exam.
exact submission · checked 2026-09-06The current Sonio family page describes DICOM worklist/PACS/VNA, HL7/FHIR and EHR connections across ultrasound manufacturers; it does not establish exact K243614 interfaces and its clinical-AI footnote refers to Sonio Detect.
product family · checked 2026-09-07The exact labeling permits the user to override the per-finding status, and current Sonio terms preserve physician judgment as the controlling boundary.
product family · checked 2026-09-07Regulatory identity
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
Research record
This audit distinguishes completed source review from fields that have not yet been researched.
The stored candidate metadata contained empty PubMed and clinical-trial ID arrays; metadata was screened, not full-text or registry-reviewed. The stored recall candidate record was empty and no event was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, vendor documentation, vendor product page, vendor terms, peer reviewed publication, clinical trial registry, recall database, pubmed, clinical trials, openfda device recall
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
No numeric price was published in the reviewed sources.
Bounded web search on 2026-10-26 (query: "Sonio Suspect reimbursement CPT"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. This records what was found, not that none exists; eligibility depends on payer, site of service and use case.
Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.
Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.
10 sources - 3 history items
Scope: regulatoryIdentity, purpose, modality, anatomy
Scope: regulatoryIdentity, modalityContext
Scope: intendedUsers, careSetting, output, reportedSensitivity, reportedSpecificity, evidenceSummary, anatomy, evidenceStudies
Scope: evidenceDiscovery
Scope: evidenceDiscovery, studyStatus
Scope: recallDiscovery, nativeSubmissionMatching
Scope: identity, intended_use, performance, limitations, implementation
Scope: product_family, cloud_workflow, DICOM_worklist, HL7_FHIR, ultrasound_integration
Scope: product_family, Sonio_Suspect_purpose, limitations, account_terms, data_ownership
Scope: security
Regulatory record
510(k)
Research record
human reviewed
Editorial review
Source-reviewed editorial overlay
Alternatives
Sonio
Authorized purpose: Concurrent physician reading aid for specified abnormal fetal ultrasound findings; patient management must not rely solely on the analysis.
Butterfly Network, Inc.
Authorized purpose: Butterfly Gestational Age Tool estimates gestational age for a singleton intrauterine pregnancy presumed to be 16 to 37 weeks within the labeled Butterfly ultrasound workflow; qualified professionals must review the output.
Bioticsai, Inc.
Authorized purpose: BioticsAI assists healthcare professionals during and after fetal ultrasound acquisition and interpretation by detecting views and anatomical structures and facilitating quality-criteria verification on DICOM images and frames; it is a concurrent reading aid for the labeled GE ultrasound and prenatal population.
BrightHeart
Authorized purpose: Automatic standard-view detection and frame extraction to support acquisition and interpretation of second- or third-trimester fetal heart ultrasound.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Open existing correction destinationPermission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.
Correction policy and limits · Public repository change history